GlucoModicum
GlucoModicum is a Finnish MedTech company pioneering a revolutionary needle-free continuous glucose monitoring (CGM) technology using magnetohydrodynamic (MHD) principles. Their flagship product, the Talisman sensor, non-invasively samples interstitial fluid through the skin to measure glucose levels rapidly and gently, representing the first new technology category in glucose monitoring in 25 years. The company combines advanced bioelectronics, biochemistry, physics, AI, and embedded software to create an integrated product blueprint optimized for mass manufacturing. GlucoModicum has a multidisciplinary team with senior professors and PhDs, a global intellectual property portfolio, and is progressing through clinical trials and towards large-scale manufacturing and commercialization. Their technology aims to provide a precise, needle-free alternative to traditional glucose monitors, targeting diabetic patients and healthcare providers globally.
GlucoModicum
GlucoModicum is a Finnish MedTech company pioneering a revolutionary needle-free continuous glucose monitoring (CGM) technology using magnetohydrodynamic (MHD) principles. Their flagship product, the Talisman sensor, non-invasively samples interstitial fluid through the skin to measure glucose levels rapidly and gently, representing the first new technology category in glucose monitoring in 25 years. The company combines advanced bioelectronics, biochemistry, physics, AI, and embedded software to create an integrated product blueprint optimized for mass manufacturing. GlucoModicum has a multidisciplinary team with senior professors and PhDs, a global intellectual property portfolio, and is progressing through clinical trials and towards large-scale manufacturing and commercialization. Their technology aims to provide a precise, needle-free alternative to traditional glucose monitors, targeting diabetic patients and healthcare providers globally.